Kilburn & Strode
Amy Nick is an Associate Patent Attorney at Kilburn & Strode since February 2021, specializing in biotechnology with a focus on antibodies, antibody engineering, mRNA therapeutics, T cell receptors, and CAR-T therapy. Previous experience includes roles at Mathys & Squire LLP from November 2016 to January 2021 and technical assistance at the UCL Institute of Neurology from September 2012 to October 2016. Amy holds a PhD in Clinical Neuroscience from UCL Institute of Neurology, a PG Cert in Intellectual Property Law from Queen Mary University of London, and a BSc in Neuroscience from UCL. Research expertise encompasses transgenic models of neurological disease, neuropharmacology, and various advanced research techniques.